Tag: #Dr Reddy’s Laboratories Lt

Hyderabad, May 12 (UNI) Dr Reddy’s Laboratories on Wednesday announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of INVANZ (ertapenem for injection) in the US market. The injection, 1 g/vial was approved by the US Food and Drug Administration (USFDA), Hyderabad based pharmaceutical giant said in a release here. “We are pleased to bring this important product to market at this time,” said Marc Kikuchi, CEO, North America Generics, Dr Reddy’s Laboratories. “We’re excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr. Reddy’s, has enabled the execution of this launch.”

Hyderabad, May 12 (UNI) Dr Reddy’s Laboratories Lt on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for the manufacture and commercialization of the drug, baricitinib, in India. The drug baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organization (CDSCO), for use in combination with remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO), Hyderabad based pharmaceutical giant said in a release here.